The US Food and Drug Administration (FDA) has granted 510(k) clearance to 4DMedical’s non-contrast, computed tomography (CT)-based ventilation-perfusion imaging technology, CT:VQ, for respiratory ...

4DMedical Limited has unveiled its innovative CT:VQ technology at RSNA 2024, offering a revolutionary alternative to traditional Nuclear VQ scans. This new imaging solution promises faster, safer, and ...

Educating physicians about ventilation-perfusion scanning (VQ) as an alternative to CT for the diagnosis of pulmonary embolisms led to a 23% decrease in patient exposure, according to a study ...

4DMedical Ltd (AU:4DX) has released an update. 4DMedical Ltd has secured $1.9 million in non-dilutive funding from the Australian government’s CRC-P grant program to advance its CT:VQ clinical trials.

Shares in 4D Medical have soared up to 33%, after the US FDA approved the company’s CT:VQ lung imaging test for ventilation perfusion. The news sent 4D shares soaring up to 40%. 4D Medical describes ...

In the emergency department (ED), it has become common practice to treat deep venous thrombosis (DVT) “below the knee” with enoxaparin (Lovenox) injection prior to discharge, followed by warfarin ...

4DMedical Ltd (AU:4DX) has released an update. Don't Miss our Black Friday Offers: 4DMedical Limited has unveiled its innovative CT:VQ technology at RSNA 2024, offering a revolutionary alternative to ...